Document:

Exhibit

EXHIBIT  4.5

STONEGATE MORTGAGE CORPORATION 2016 OMNIBUS INCENTIVE COMPENSATION PLAN
OPTION AGREEMENT
THIS OPTION AGREEMENT (this “Agreement”), dated as of the  day of [Month], [Year] (the “Grant Date”), is by and between STONEGATE MORTGAGE CORPORATION, an Ohio corporation (the “Company”), and [GRANTEE] (the “Grantee”), pursuant to the Stonegate Mortgage Corporation 2016 Omnibus Incentive Compensation Plan, as may be amended from time to time (the “Plan”).
1. Grant of Options. Subject to the terms and conditions set forth herein and in the Plan, the Company hereby grants to the Grantee stock options to purchase  Shares (the “Stock Options”) at the exercise price of $[xxxx.xx] per Share (the “Exercise Price”) (which may not be less than the Fair Market Value of a Share on the Grant Date), subject to adjustment in certain events as set forth in the Plan.
2. Nonqualified Stock Options. The Stock Options are nonqualified stock options and are not intended to qualify as “incentive stock options” under Section 422 of the Code and, as such, shall not be entitled to the benefits set forth in Section 422 of the Code.
3. Vesting and Exercise.
(a) Vesting. None of the Stock Options shall be exercisable until they have vested. Except as otherwise provided herein, the Stock Options granted hereunder shall vest, and thereby become exercisable subject to the terms and conditions set forth herein and in the Plan, in equal annual installments of [25]% on each of the [first through fourth] anniversaries of the Grant Date, and shall be exercisable, only to the extent vested, and shall be subject to the terms and conditions herein. The Stock Options shall cease to vest upon the occurrence of a Termination Event, subject to Section 4 below. Notwithstanding the foregoing, the Committee may, in its sole discretion, accelerate the vesting of any unvested Stock Options.
(b) Exercise. Subject to the terms and conditions in the Plan and in this Agreement, vested Stock Options may be exercised at any time after vesting but no later than the tenth anniversary of the Grant Date (the “Expiration Date”) on which date all unexercised Stock Options shall terminate and be forfeited to the Company. In order to exercise a vested Stock Option, the Grantee shall provide written notice of exercise to the Company, attention [    ] of the Company, stating in that notice the date of exercise and specifying the number of Shares to be acquired. Notwithstanding the foregoing, Stock Options granted hereunder may not be exercised unless such exercise is in compliance, to the reasonable satisfaction of the Committee, with all applicable federal and state securities laws, the requirements of any stock exchange with which the Shares may be listed and other applicable rules or regulations, in each case, as may be in effect on the date of exercise.
(c) Payment and Issuance of Shares. Upon exercise, the Grantee shall pay the Exercise Price for such exercised Stock Options in cash or by certified or official bank check or in another form as determined by the Company, which may include personal check, Shares (based on Fair Market Value as of the exercise date), any other form of consideration approved by the Company and permitted by law and any combination of the foregoing, on the date of exercise and the Company agrees to issue to the Grantee the applicable number of Shares on such date. The Company may postpone such issuance until it receives satisfactory proof that the issuance of such Shares will not violate any of the provisions of the Securities Act of 1933, as amended, or the Securities and Exchange Act of 1934, as amended, or the requirements of applicable state law or other laws, rules or regulations relating to authorization, issuance or sale of securities, or until there has been compliance with the provisions of such acts or rules. The Grantee understands that the Company is under no obligation to register or qualify the Shares with the Securities and Exchange Commission, any state securities commission or any stock exchange to effect such compliance.
4. Effect of Termination Event on Options. If a Grantee has a Termination Event, (i) all of the Stock Options that have not vested as of the Termination Date shall be cancelled by the Company and forfeited by the Grantee as of the Termination Date and (ii) any Stock Options that had previously vested as of the Termination Date shall be canceled by the Company and forfeited by the Grantee on the earlier of (A) the date that is three months after the Termination Date and (B) the Expiration Date, provided, however, that if the Grantee has a Termination Event due to death or Disability, or dies during the three months f

ollowing a Termination Event, the Stock Options shall terminate on the earlier of (A) the date that is one year after the Termination Date and (B) the Expiration Date, as provided in the Plan.
5. Change in Control. Upon a Change in Control, the terms of Section 3.7 of the Plan shall govern treatment of this Award.
6. Ownership, Voting Rights, Duties. The Grantee will not have any rights of a stockholder of the Company with respect to the Shares subject to this Award until the delivery of such Shares.
7. Transferability and Resale Restrictions. The Stock Options may not be sold, exchanged, transferred, assigned, pledged, hypothecated or otherwise disposed of or hedged, in any manner (including through the use of any cash-settled instrument), whether voluntarily or involuntarily and whether by operation of law or otherwise, other than by will or by the laws of descent and distribution, and except as set forth in Section 3.5 of the Plan and Section 4 above, all such Stock Options will be exercisable during the life of the Grantee only by the Grantee or the Grantee’s legal representative. All of the terms and conditions of the Plan and this Agreement will be binding upon any permitted successors and assigns.
 
8. Tax Representations and Tax Withholding. The Grantee acknowledges that the Grantee does not construe the contents of this Agreement or the Plan or any other information (whether written or oral) provided to the Grantee as legal, business or tax advice. The Grantee represents and warrants that the Grantee has had the opportunity to consult the Grantee’s personal legal counsel, accountant and other advisors as to legal, tax, economic and related matters regarding this Agreement and the Plan and/or an investment in the Shares and their suitability for the Grantee. The Grantee understands that the Grantee shall be solely responsible for any applicable taxes (including, without limitation, income and excise taxes) and penalties, and any interest that accrues thereon, that he or she incurs in connection with this investment or the transactions contemplated by this Agreement. The Company may require the Grantee to pay to the Company, or make arrangements satisfactory to the Company regarding payment of, any taxes of any kind required by law to be withheld with respect to the Shares.
9. Entire Agreement; Plan Controlling. The Grantee agrees that, except to the extent set forth herein, this Agreement and the Plan contain the entire agreement of the parties with respect to the subject matter hereof and supersede all prior agreements, promises, covenants, arrangements, communications, representations and warranties between them, whether written or oral with respect to the subject matter hereof. The Grantee agrees that the Plan is incorporated herein by reference. If and to the extent that any provision of this Agreement conflicts or is inconsistent with the terms, conditions and provisions of the Plan, the Plan shall control, and such provision of this Agreement shall be deemed modified to the extent, but only to the extent, of such conflict or inconsistency. The determination of the Committee on all matters relating to the Plan or this Agreement will be final, binding and conclusive. Capitalized terms not defined in this Agreement have the meanings as used or defined in the Plan. The Grantee acknowledges that the Grantee has received a copy of the Plan and that to the extent the Grantee needs an additional copy of the Plan one can be obtained at any time by contacting the [    ] of the Company.
10. Miscellaneous.
(a) Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Ohio, without reference to the principles of conflict of laws.
(b) Notices. All notices or other communications required or permitted under the terms of this Agreement must be in writing (except as otherwise specifically provided herein) and must be given by personal delivery, by express delivery service or by certified or registered U.S. mail, postage prepaid, return receipt requested. Notice to the Corporation must be addressed to the principal office of the Corporation or to any other address as the Corporation has subsequently furnished in writing to the Grantee for that purpose, Attention Chairman of the Board. Notices to the Grantee must be addressed to the Grantee’s current addresses appearing on the books and records of the Corporation.
(c) Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same agreement.
 
(d) Venue. In accordance with Section 3.17 of the Plan, the Company and the Grantee hereby irrevocably submit to the exclusive jurisdiction of any state or federal court located in the County of Marion, State of Indiana, over any suit, action or proceeding arising out of or relating to or concerning the Plan or proceeding arising out of or relating to or concerning the Plan or this Agreement.
(e) Severable. In case any provision of this Agreement shall be illegal or invalid for any reason, said illegality or invalidity shall not affect the remaining parts hereof, but this Agreement shall be construed and enforced as if such illegal or invalid provision had never been inserted herein.

(f) No Right to Continued Employment. Nothing in the Plan or this Agreement shall confer upon the Grantee any right to continued employment or continued engagement, nor shall it interfere in any way with the right of the Company or any Affiliate to terminate the employment or engagement of the Grantee at any time.
(g) Amendment. The Committee may amend the Plan and this Agreement in any respect whatsoever, provided that any such amendment that materially adversely impairs any rights of the Grantee under this Agreement shall be made only with the consent of the Grantee.
(h) Headings. The headings in this Agreement are for the purpose of convenience only and are not intended to define or limit the construction of the provisions hereof.
 
IN WITNESS WHEREOF, the parties have caused this Agreement to be executed and delivered as of the date first written above.
 
	
				
	 
	“Corporation”
 
STONEGATE MORTGAGE CORPORATION

	 
	 
	 

	 
	By:
	 
	 

	 
	 

	 
	“Grantee”

	 
	 

	 
	 

	 
	                [Grantee]Lightbridge Corp.: Exhibit 4.3 - Filed by newsfilecorp.com

THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON
EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS AND MAY NOT BE
SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE
EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE
TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
ACCEPTABLE TO THE COMPANY. 

LIGHTBRIDGE CORPORATION 

FORM OF WARRANT TO PURCHASE COMMON SHARES 

Warrant No.: ____________
Number of Common Shares:
_____________
Date of Issuance: ____________(“Issuance Date”) 

Lightbridge Corporation, a Nevada
corporation (the “Company”), hereby certifies that, for good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged,
_____________, the registered holder hereof or its permitted assigns (the
“Holder”), is entitled, subject to the terms set forth below, to purchase
from the Company, at the Exercise Price (as defined below) then in effect, upon
surrender of this Warrant to Purchase Common Shares (including any Warrants to
Purchase Common Shares issued in exchange, transfer or replacement hereof, the
“Warrant”), at any time or times after the Issuance Date, but not after
5:00 p.m., New York time, on the Expiration Date (as defined below),
__________
(________) (subject to adjustment as provided herein) fully paid,
nonassessable Common Shares (as defined below) (the “Warrant Shares”).
Except as otherwise defined herein, capitalized terms in this Warrant shall have
the meanings set forth in Section 16. 

1. EXERCISE OF WARRANT.

(a) Mechanics of Exercise.
Subject to the terms and conditions hereof, this Warrant may be exercised by the
Holder on any day after the Issuance Date, in whole or in part, by delivery of a
written notice, in the form attached hereto as Exhibit A (the “Exercise
Notice”), of the Holder’s election to exercise this Warrant. Within two (2)
days following the Exercise Notice, the Holder shall make payment to the Company
of an amount equal to the applicable Exercise Price multiplied by the number of
Warrant Shares as to which this Warrant is being exercised (the “Aggregate
Exercise Price”) in cash or by wire transfer of immediately available funds,
or provided the conditions for cashless exercise set forth in Section
1(e) are satisfied, by notifying the Company that this Warrant is being
exercised pursuant to a Cashless Exercise (as defined in Section 1(e)).
Execution and delivery of the Exercise Notice with respect to less than all of
the Warrant Shares shall have the same effect as cancellation of the original
Warrant and issuance of a new Warrant evidencing the right to purchase the
remaining number of Warrant Shares. On or before the first (1st) Business Day
following the date on which the Company has received the Exercise Notice, the
Company shall transmit by facsimile an acknowledgment of confirmation of receipt
of the Exercise Notice to the Holder and the Company’s transfer agent (the
“Transfer Agent”). On or before the third (3rd) Business Day following
the date on which the Company has received the Exercise Notice (the “Share
Delivery Date”), the Company shall (X) provided that the Transfer Agent is
participating in The Depository Trust Company (“DTC”) Fast Automated
Securities Transfer Program (the “FAST Program”), upon the request of the
Holder, credit such aggregate number of Common Shares to which the Holder is
entitled pursuant to such exercise to the Holder’s or its designee’s balance account with DTC through
its Deposit Withdrawal Agent Commission system, or (Y), if the Transfer Agent is
not participating in the FAST Program, issue and dispatch by overnight courier
to the address as specified in the Exercise Notice, a certificate, registered in
the Company’s share register in the name of the Holder or its designee, for the
number of Common Shares to which the Holder is entitled pursuant to such
exercise. The Warrant Shares so purchased shall be deemed to be issued to the
Holder or the Holder’s designee, as the record owner of such Warrant Shares, as
of the close of business on the date of exercise. If this Warrant is submitted
in connection with any exercise pursuant to this Section 1(a) and the number of
Warrant Shares represented by this Warrant submitted for exercise is greater
than the number of Warrant Shares being acquired upon an exercise, then the
Company shall as soon as practicable and in no event later than three (3)
Business Days after any exercise and at its own expense, issue a new Warrant (in
accordance with Section 7(d)) representing the right to purchase the
number of Warrant Shares purchasable immediately prior to such exercise under
this Warrant, less the number of Warrant Shares with respect to which this
Warrant is exercised. No fractional Common Shares are to be issued upon the
exercise of this Warrant, but rather the Company shall pay to Holder cash equal
to the product of such fraction multiplied by the Closing Sale Price of one
Warrant Share on the Share Delivery Date. The Company shall pay any and all
transfer taxes and transfer agent fees which may be payable with respect to the
issuance and delivery of Warrant Shares to the Holder upon exercise of this
Warrant. 

(b) Exercise Price. For
purposes of this Warrant, “Exercise Price” means $0.01 per Warrant Share,
subject to adjustment as provided herein. 

(c) Disputes. In the case
of a dispute as to the determination of the Exercise Price or the arithmetic
calculation of the Warrant Shares, the Company shall promptly issue to the
Holder the number of Warrant Shares that are not disputed. 

(d) Limitations On
Exercise. The Company shall not effect the exercise of this Warrant, and the
Holder shall not have the right to exercise this Warrant, to the extent that
after giving effect to such exercise, such Person (together with such Person’s
affiliates) would beneficially own in excess of 4.99% (the “Maximum
Percentage”) of the Common Shares outstanding immediately after giving
effect to such exercise. For purposes of the foregoing sentence, the aggregate
number of Common Shares beneficially owned by such Person and its affiliates
shall include the number of Common Shares issuable upon exercise of this Warrant
with respect to which the determination of such sentence is being made, but
shall exclude Common Shares which would be issuable upon (i) exercise of the
remaining, unexercised portion of this Warrant beneficially owned by such Person
and its affiliates and (ii) exercise or conversion of the unexercised or
unconverted portion of any other securities of the Company beneficially owned by
such Person and its affiliates (including, without limitation, any convertible
notes or convertible shares or warrants) subject to a limitation on conversion
or exercise analogous to the limitation contained herein. Except as set forth in
the preceding sentence, for purposes of this paragraph, beneficial ownership
shall be calculated in accordance with Section 13(d) of the Securities Exchange
Act of 1934, as amended (the “Exchange Act”). For purposes of this
Warrant, in determining the number of outstanding Common Shares, the Holder may
rely on the number of outstanding Common Shares as reflected in the most recent
of (1) the Company’s most recent Form 10-K, Form 10-Q or other public filing
with the Securities and Exchange Commission, as the case may be, (2) a more
recent public announcement by the Company or (3) any other notice by the Company
or the Transfer Agent setting forth the number of Common Shares outstanding. For
any reason at any time, upon the written or oral request of the Holder, the
Company shall within two (2) Business Days confirm to the Holder the number of
Common Shares then outstanding. In any case, the number of outstanding Common
Shares shall be determined after giving effect to the conversion or exercise of
securities of the Company, including this Warrant, by the Holder and its
affiliates since the date as of which such number of outstanding Common Shares
was reported. By written notice to the Company, the Holder may from time to time increase or decrease
the Maximum Percentage to any other percentage not in excess of 19.99% specified
in such notice; provided that (i) any such increase will not be effective until
the sixty-first (61st) day after such notice is delivered to the Company, and
(ii) any such increase or decrease will apply only to the Holder. The provisions
of this paragraph shall be construed, corrected and implemented in a manner so
as to effectuate the intended beneficial ownership limitation herein contained.
The limitations contained in this paragraph shall apply to any successor Holder
of this Warrant.

1

(e) Cashless Exercise. The
Holder may, as its election, or shall, if a registration statement permitting
the registered issuance of the Warrant Shares is not then effective, or the
prospectus forming a part thereof is not then available, utilize cashless
exercise, in which event the Company shall issue to the Holder the number of
Warrant Shares determined as follows (a “Cashless Exercise”): 

X = Y [(A-B)/A] 

where: 

X = the number of Warrant Shares to be
issued to the Holder.
Y = the number of Warrant Shares with respect to which
this Warrant is being exercised.
A = the VWAP for the five (5) Trading Days
immediately prior to (but not including) the date of delivery of the Exercise
Notice.
B = the Exercise Price.

Upon receipt of an Exercise
Notice to which this Section 1(e) is applicable, the Company shall notify
the Holder within one (1) Trading Day of such applicability and the calculation
of the Warrant Shares issuable upon the noticed exercise of the Warrant
utilizing cashless exercise, and confirm the Holder’s desire to complete the
exercise of the Warrant pursuant to this Section 1(e).

For purposes of Rule 144
promulgated under the Securities Act of 1933, as amended, it is intended,
understood and acknowledged that the Warrant Shares issued in a cashless
exercise transaction shall be deemed to have been acquired by the Holder, and
the holding period for the Warrant Shares shall be deemed to have commenced, on
the date this Warrant was originally issued.

(f) Compliance with Securities
Laws; Transfer Restrictions. 

(i) The Holder, by acceptance
hereof, acknowledges that this Warrant and the Warrant Shares are being or shall
be acquired solely for the Holder’s own account and not as a nominee for any
other party, and for investment, and that the Holder will not offer, sell or
otherwise dispose of this Warrant or any Warrant Shares except pursuant to an
effective registration statement, or an exemption from registration, under the
Securities Act and any applicable state securities laws. 

(ii) Except as provided in
paragraph (iii) below, all certificates representing Warrant Shares shall be
stamped or imprinted with a legend in substantially the following form: 

THE
SHARES OF COMMON STOCK REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
  ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR ANY STATE SECURITIES LAWS AND
  MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN
  EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
  AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
  REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
  OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH
SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. 

2

(iii) Certificates evidencing the
Warrant Shares shall be eligible for removal of the restrictive legend set forth
in paragraph (ii) above, (a) if such Warrant Shares are eligible for sale under
Rule 144, (b) following any sale of such Warrant Shares, pursuant to the plan of
distribution in an effective registration statement (in compliance with any
prospectus delivery requirements), or (c) if such legend is not required under
applicable requirements of the Securities Act (including judicial
interpretations and pronouncements issued by the staff of the Commission) (the
“Removal Date”). The Company shall cause its counsel to issue a legal
opinion to the Transfer Agent promptly after the Removal Date if required by the
Transfer Agent to effect the removal of the legend hereunder as permitted by
applicable law then in effect. The Company agrees that following the Removal
Date, it will, no later than five (5) trading days following the delivery by the
Holder to the Company or the Transfer Agent of a certificate representing
Warrant Shares issued with a restrictive legend, together with any reasonable
certifications requested by the Company, the Company’s counsel or the Transfer
Agent (such fifth (5th) trading day, the “Legend Removal Date”), deliver
or cause to be delivered to the Holder a certificate representing such shares
that is free from all restrictive and other legends. The Company may not make
any notation on its records or give instructions to the Transfer Agent that
enlarge the restrictions on transfer set forth in this Section 1(f).
Certificates for Warrant Shares subject to legend removal hereunder shall be
transmitted by the Transfer Agent to the Holder by crediting the account of the
Holder’s prime broker with the Depository Trust Company System as directed by
the Holder if the Transfer Agent is then a participant in such system and the
Company is eligible to use such system and as directed by the Holder if either
(i) there is an effective registration statement permitting the resale of such
Warrant Shares by the Holder (and the Holder provides the Company or the
Company’s counsel with any requested certifications with respect to future sales
of such shares) or (ii) the shares are eligible for resale by the Holder under
Rule 144. 

(iv) The restrictions imposed by
this subsection (f) upon the transfer of this Warrant or the Warrant Shares
shall terminate (A) when such securities shall have been resold pursuant to an
effective registration statement under the Securities Act, (B) upon an available
exemption from, or a transaction not subject to, the registration requirements
of the Securities Act and in accordance with applicable state securities laws as
evidenced by a legal opinion of counsel to the transferor to such effect, the
substance of which shall be reasonably acceptable to the Company, or (C) upon
the Company’s receipt of other evidence reasonably satisfactory to the Company
that such registration and qualification under the Securities Act and state
securities laws are not required. Whenever such restrictions shall cease and
terminate as to any such securities, the Holder shall be entitled to receive
from the Company (or its transfer agent and registrar), without expense (other
than applicable transfer taxes, if any), new Warrants (or, in the case of
Warrant Shares, new stock certificates) of like tenor not bearing the applicable
legend appearing on the face of this Warrant or required by paragraph (ii) above
relating to the Securities Act and state securities laws. 

(g) Company’s Failure to
Timely Deliver Securities. If the Company shall fail for any reason or for
no reason to issue to the Holder within three (3) Business Days after the Share
Delivery Date or Legend Removal Date in compliance with the terms of this
Section 1, a certificate for the number of Common Shares to which the
Holder is entitled and register such Common Shares on the Company’s share
register or to credit the Holder’s balance account with DTC for such number of
Common Shares to which the Holder is entitled upon the Holder’s exercise of this
Warrant, and if on or after such Trading Day the Holder, or any third party on
behalf of the Holder or for the Holder’s account, purchases (in an open market
transaction or otherwise) Common Shares to deliver in satisfaction of a sale by
the Holder of Common Shares issuable upon such exercise that the Holder
anticipated receiving from the Company (a “Buy-In”), then the
Company shall, within three (3) Business Days after the Holder’s request,
promptly honor its obligation to deliver to the Holder a certificate or
certificates representing such Warrant Shares and pay cash to the Holder in an
amount equal to the excess (if any) of the Buy-In Price over the product of (A)
such number of Common Shares, times (B) the Closing Sale Price on the Share
Delivery Date. Notwithstanding anything herein to the contrary, the Company
shall not be required to make any cash payments to the Holder in lieu of
issuance of the Warrant Shares. 

3

2. ADJUSTMENT OF EXERCISE
PRICE AND NUMBER OF WARRANT SHARES. The Exercise Price and the number of
Warrant Shares shall be adjusted from time to time as follows: 

(a) Adjustment upon
Subdivision or Combination of Common Shares. If the Company at any time on
or after the Issuance Date subdivides (by any share split, share dividend,
recapitalization or otherwise) one or more classes of its outstanding Common
Shares into a greater number of shares, the Exercise Price in effect immediately
prior to such subdivision will be proportionately reduced and the number of
Warrant Shares will be proportionately increased. If the Company at any time on
or after the Issuance Date combines (by any reverse share split,
recapitalization or otherwise) one or more classes of its outstanding Common
Shares into a smaller number of shares, the Exercise Price in effect immediately
prior to such combination will be proportionately increased and the number of
Warrant Shares will be proportionately decreased. Any adjustment under this
Section 2(a) shall become effective at the close of business on the date
the subdivision or combination becomes effective. 

(b) Other Events. If any
event occurs of the type contemplated by the provisions of this Section 2
but not expressly provided for by such provisions (including, without
limitation, the granting of share appreciation rights or phantom share rights to
all shareholders), then the Company’s Board of Directors will make an
appropriate adjustment in the Exercise Price and the number of Warrant Shares so
as to protect the rights of the Holder; provided that no such adjustment
pursuant to this Section 2(b) will increase the Exercise Price or
decrease the number of Warrant Shares as otherwise determined pursuant to this
Section 2. 

(c) Calculations. All
calculations made under this Section 2 shall be made by rounding to the nearest
cent or the nearest 1/100th of a Common Share, as applicable.

3. RIGHTS UPON DISTRIBUTION OF
ASSETS.

(a) If the Company shall declare
or make any dividend or other distribution of its assets (or rights to acquire
its assets) to holders of Common Shares, by way of return of capital or
otherwise (including, without limitation, any distribution of cash, stock or
other securities, property or options by way of a dividend, spin off,
reclassification, corporate rearrangement, scheme of arrangement or other
similar transaction) (a “Distribution”), at any time after the issuance
of this Warrant, then, in each such case: 

(i) any Exercise Price in effect
immediately prior to the close of business on the record date fixed for the
determination of holders of Common Shares entitled to receive the Distribution
shall be reduced, effective as of the close of business on such record date, to
a price determined by multiplying such Exercise Price by a fraction of which (A)
the numerator shall be the VWAP of the Common Shares on the Trading Day
immediately preceding such record date minus the value of the Distribution (as
determined in good faith by the Company’s Board of Directors) applicable to one
Common Share, and (B) the denominator shall be the VWAP of the Common Shares on
the Trading Day immediately preceding such record date; and; 

(ii) the number of Warrant Shares
shall be increased to a number of shares equal to the number of Common Shares
obtainable immediately prior to the close of business on the record date fixed for the determination of holders of Common Shares
entitled to receive the Distribution multiplied by the reciprocal of the
fraction set forth in the immediately preceding paragraph (a)(i). 

4

(b) Upon the occurrence of each
adjustment pursuant to this Section 3, the Company at its expense will,
at the written request of the Holder, promptly compute such adjustment in
accordance with the terms of this Warrant and prepare a certificate setting
forth such adjustment, including a statement of the adjusted Exercise Price and
number or type of Warrant Shares describing the transactions giving rise to such
adjustments and showing in detail the facts upon which such adjustment is based,
including the expiration date of any applicable options, warrants or rights.
Upon written request, the Company will promptly deliver a copy of each such
certificate to the Holder and to the Transfer Agent. All calculations made under
this Section 3 shall be made by rounding to the nearest cent or the
nearest 1/100th of any security, as applicable.

4. FUNDAMENTAL
TRANSACTIONS. Upon the occurrence of any Fundamental Transaction, any
Successor Entity shall succeed to, and be substituted for (so that from and
after the date of such Fundamental Transaction, the provisions of this Warrant
referring to the “Company” shall refer instead to any Successor Entity), and may
exercise every right and power of the Company and shall assume all of the
obligations of the Company under this Warrant with the same effect as if such
Successor Entity had been named as the Company herein. Upon consummation of the
Fundamental Transaction, any Successor Entity shall deliver to the Holder
confirmation that there shall be issued upon exercise of this Warrant at any
time after the consummation of the Fundamental Transaction, in lieu of the
shares of the Common Stock (or other securities, cash, assets or other property
purchasable upon the exercise of the Warrant prior to such Fundamental
Transaction), such shares of stock, securities, cash, assets or any other
property whatsoever (including warrants or other purchase or subscription
rights), if any, that the Holder would have been entitled to receive upon the
happening of such Fundamental Transaction had this Warrant been exercised
immediately prior to such Fundamental Transaction, as adjusted in accordance
with the provisions of this Warrant. In addition to and not in substitution for
any other rights hereunder, prior to the consummation of any Fundamental
Transaction pursuant to which holders of shares of Common Stock are entitled to
receive securities or other assets with respect to or in exchange for shares of
Common Stock (a “Corporate Event”), the Company shall make appropriate
provision to insure that the Holder will thereafter have the right to receive
upon an exercise of this Warrant within 90 days after the consummation of the
Fundamental Transaction but, in any event, prior to the Expiration Date, in lieu
of the shares of the Common Stock (or other securities, cash, assets or other
property) purchasable upon the exercise of the Warrant prior to such Fundamental
Transaction, such shares of stock, securities, cash, assets or any other
property whatsoever (including warrants or other purchase or subscription
rights) which the Holder would have been entitled to receive upon the happening
of such Fundamental Transaction had the Warrant been exercised immediately prior
to such Fundamental Transaction. The Company shall not enter into or be a party
to a Fundamental Transaction unless provision is made with respect to the
holder’s right under this Section 4 in a form and substance reasonably
satisfactory to the Holder. If holders of Common Stock are given any choice as
to the securities, cash or property to be received in a Fundamental Transaction,
then the Holder shall be given the same choice as to the consideration it
receives upon any exercise of this Warrant following such Fundamental
Transaction. The provisions of this Section shall apply similarly and equally to
successive Fundamental Transactions and Corporate Events and shall be applied
without regard to any limitations on the exercise of this Warrant. The Holder
may waive its rights under this Section 4 with respect to any particular
Fundamental Transaction. 

5. NONCIRCUMVENTION. The
Company hereby covenants and agrees that the Company will not, by amendment of
its Certificate of Incorporation or through any reorganization, transfer of
assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale
of securities, or any other voluntary action, avoid or seek to avoid the
observance or performance of any of the terms of this Warrant, and will at all times in good faith comply with all
the provisions of this Warrant and take all actions consistent with effectuating
the purposes of this Warrant. Without limiting the generality of the foregoing,
the Company (i) shall not increase the par value of any Common Shares receivable
upon the exercise of this Warrant above the Exercise Price then in effect, (ii)
shall take all such actions as may be necessary or appropriate in order that the
Company may validly and legally issue fully paid and nonassessable Common Shares
upon the exercise of this Warrant, and (iii) shall, so long as this Warrant is
outstanding, take all action necessary to reserve and keep available out of its
authorized and unissued Common Shares, solely for the purpose of effecting the
exercise of this Warrant, 100% of the number of Common Shares issuable upon
exercise of the Warrants then outstanding (without regard to any limitations on
exercise). 

5

6. WARRANT HOLDER NOT DEEMED A
SHAREHOLDER. Except as otherwise specifically provided herein, the Holder,
solely in such Person’s capacity as a holder of this Warrant, shall not be
entitled to vote or receive dividends or be deemed the holder of share capital
of the Company for any purpose, nor shall anything contained in this Warrant be
construed to confer upon the Holder, solely in such Person’s capacity as the
Holder of this Warrant, any of the rights of a shareholder of the Company or any
right to vote, give or withhold consent to any corporate action (whether any
reorganization, issue of shares, reclassification of shares, consolidation,
merger, conveyance or otherwise), receive notice of meetings, receive dividends
or subscription rights, or otherwise, prior to the issuance to the Holder of the
Warrant Shares which such Person is then entitled to receive upon the due
exercise of this Warrant. In addition, nothing contained in this Warrant shall
be construed as imposing any liabilities on the Holder to purchase any
securities (upon exercise of this Warrant or otherwise) or as a shareholder of
the Company, whether such liabilities are asserted by the Company or by
creditors of the Company. Notwithstanding this Section 6, the Company
shall provide the Holder with copies of the same notices and other information
given to the shareholders of the Company generally, contemporaneously with the
giving thereof to the shareholders, provided that any such notice or information
published via international wire or furnished to or filed with the U.S.
Securities and Exchange Commission shall satisfy this requirement.

7. REISSUANCE OF WARRANTS; NO
FRACTIONAL SHARES. 

(a) Transfer of Warrant.
If this Warrant is to be transferred, the Holder shall surrender this Warrant to
the Company and deliver the completed and executed Assignment Form, in the form
attached hereto as Exhibit B, whereupon the Company will forthwith issue
and deliver upon the order of the Holder a new Warrant (in accordance with
Section 7(d)), registered as the Holder may request, representing the
right to purchase the number of Warrant Shares being transferred by the Holder
and, if less than the total number of Warrant Shares then underlying this
Warrant is being transferred, a new Warrant (in accordance with Section
7(d)) to the Holder representing the right to purchase the number of Warrant
Shares not being transferred. 

(b) Lost, Stolen or Mutilated
Warrant. Upon receipt by the Company of evidence reasonably satisfactory to
the Company of the loss, theft, destruction or mutilation of this Warrant, and,
in the case of loss, theft or destruction, of any indemnification undertaking by
the Holder to the Company in customary form and, in the case of mutilation, upon
surrender and cancellation of this Warrant, the Company shall execute and
deliver to the Holder a new Warrant (in accordance with Section 7(d))
representing the right to purchase the Warrant Shares then underlying this
Warrant. 

(c) Exchangeable for Multiple
Warrants. This Warrant is exchangeable, upon the surrender hereof by the
Holder at the principal office of the Company, for a new Warrant or Warrants (in
accordance with Section 7(d)) representing in the aggregate the right to
purchase the number of Warrant Shares then underlying this Warrant, and each
such new Warrant will represent the right to purchase such portion of such Warrant Shares as is designated
by the Holder at the time of such surrender; provided, however, that no
Warrants for fractional Common Shares shall be given. 

6

(d) Issuance of New
Warrants. Whenever the Company is required to issue a new Warrant pursuant
to the terms of this Warrant, such new Warrant (i) shall be of like tenor with
this Warrant, (ii) shall represent, as indicated on the face of such new
Warrant, the right to purchase the Warrant Shares then underlying this Warrant
(or in the case of a new Warrant being issued pursuant to Section 7(a) or
Section 7(c), the Warrant Shares designated by the Holder which, when
added to the number of Common Shares underlying the other new Warrants issued in
connection with such issuance, does not exceed the number of Warrant Shares then
underlying this Warrant), (iii) shall have an issuance date, as indicated on the
face of such new Warrant which is the same as the Issuance Date, and (iv) shall
have the same rights and conditions as this Warrant. 

(e) No Fractional Shares.
No fractional shares of Warrant Shares will be issued in connection with any
exercise of this Warrant. In lieu of any fractional shares which would,
otherwise be issuable, the Company shall pay to Holder cash equal to the product
of such fraction multiplied by the Closing Sale Price of one Warrant Share on
the Share Delivery Date.

8. NOTICES. All notices
required or permitted hereunder shall be in writing and shall be deemed
effectively given: (a) upon personal delivery to the party to be notified, (b)
when sent by confirmed telex or facsimile if sent during normal business hours
of the recipient, if not, then on the next Business Day, (c) three (3) days
after having been sent by registered or certified mail, return receipt
requested, postage prepaid, or (d) one (1) Business Day after deposit with a
nationally recognized overnight courier, with written verification of receipt.
All communications shall be sent to the Company or the Holder at their
respective addresses listed in Option Agreement dated August 10, 2016 (the
“Option Agreement”) or at such other address as the Company or Holder may
designate by ten (10) days advance written notice to the other parties
hereto.

9. AMENDMENT AND WAIVER.
Except as otherwise provided herein, the provisions of this Warrant may be
amended and the Company may take any action herein prohibited, or omit to
perform any act herein required to be performed by it, only if the Company has
obtained the written consent of Holders owning seventy-five percent (75%) in
interest of the outstanding Warrants issued under the Option Agreement;
provided, that (x) any such amendment or waiver must apply to all
Warrants issued by the Company pursuant to the Option Agreement; and (y) the
number of Warrant Shares subject to this Warrant, the Exercise Price and the
Expiration Date may not be amended, and the right to exercise this Warrant may
not be altered or waived, without the written consent of the Holder. No waiver
of any provision hereunder shall be effective unless it is in writing and signed
by an authorized representative of the waiving party.

10. SEVERABILITY. If any
provision of this Warrant is prohibited by law or otherwise determined to be
invalid or unenforceable by a court of competent jurisdiction, the provision
that would otherwise be prohibited, invalid or unenforceable shall be deemed
amended to apply to the broadest extent that it would be valid and enforceable,
and the invalidity or unenforceability of such provision shall not affect the
validity of the remaining provisions of this Warrant so long as this Warrant as
so modified continues to express, without material change, the original
intentions of the parties as to the subject matter hereof and the prohibited
nature, invalidity or unenforceability of the provision(s) in question does not
substantially impair the respective expectations or reciprocal obligations of
the parties or the practical realization of the benefits that would otherwise be
conferred upon the parties. The parties will endeavor in good faith negotiations
to replace the prohibited, invalid or unenforceable provision(s) with a valid
provision(s), the effect of which comes as close as possible to that of the
prohibited, invalid or unenforceable provision(s).

7

11. GOVERNING LAW. This
Warrant shall be governed by and construed and enforced in accordance with, and
all questions concerning the construction, validity, interpretation and
performance of this Warrant shall be governed by, the internal laws of the State
of Nevada, without giving effect to any choice of law or conflict of law
provision or rule (whether of the State of Nevada or any other jurisdictions)
that would cause the application of the laws of any jurisdictions other than the
State of Nevada.

12. CONSTRUCTION;
HEADINGS. This Warrant shall be deemed to be jointly drafted by the Company
and the Holder and shall not be construed against any person as the drafter
hereof. The headings of this Warrant are for convenience of reference and shall
not form part of, or affect the interpretation of, this Warrant. 

13. DISPUTE RESOLUTION. In
the case of a dispute as to the determination of the Exercise Price or the
arithmetic calculation of the Warrant Shares, the Company shall submit the
disputed determinations or arithmetic calculations via facsimile within two (2)
Business Days of receipt of the Exercise Notice giving rise to such dispute, as
the case may be, to the Holder. If the Holder and the Company are unable to
agree upon such determination or calculation of the Exercise Price or the
Warrant Shares within three (3) Business Days of such disputed determination or
arithmetic calculation being submitted to the Holder, then the Company shall,
within four (4) Business Days thereafter submit via facsimile the disputed
determination of the Exercise Price or Warrant Shares to an independent,
reputable investment bank mutually agreeable to the Company and the Holder. The
Company shall cause the investment bank to perform the determinations or
calculations and notify the Company and the Holder of the results no later than
ten (10) Business Days from the time it receives the disputed determinations or
calculations. Such investment bank’s determination or calculation, as the case
may be, shall be binding upon all parties absent demonstrable error. The
expenses of the investment bank and any other reasonable expenses incurred in
good faith in connection with any such dispute will be borne by the Company
unless the investment bank or accountant determines that the determination of
the Exercise Price or the arithmetic calculation of the Warrant Shares by the
Holder was incorrect, in which case the expenses of the investment bank and any
other reasonable expenses incurred in connection with any such dispute will be
borne by the Holder.

14. REMEDIES, OTHER
OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF. The remedies provided in this
Warrant shall be cumulative and in addition to all other remedies available
under this Warrant, at law or in equity (including a decree of specific
performance and/or other injunctive relief), and nothing herein shall limit the
right of the Holder to pursue actual damages for any failure by the Company to
comply with the terms of this Warrant. For the avoidance of doubt and
notwithstanding anything herein to the contrary, the Company may not substitute,
and the Holder may not request, a cash payment in satisfaction of the Company’s
obligation to issue and deliver Warrant Shares pursuant to an Exercise Notice or
otherwise. 

15. TRANSFER. This Warrant
may be offered for sale, sold, transferred, hypothecated or assigned without the
consent of the Company, subject to compliance with Section 1(f) hereof. 

16. CERTAIN DEFINITIONS.
For purposes of this Warrant, the following terms shall have the following
meanings: 

(a) “Business Day” means
any day other than Saturday, Sunday or other day on which commercial banks in
The City of New York are authorized or required by law to remain closed. 

(b) “Closing Sale Price”
means, for any security as of any date, the last closing trade price for such
security on the Principal Market, as reported by Bloomberg, L.P.
(“Bloomberg”), or, if the Principal Market begins to operate on an extended hours basis
and does not designate the closing trade price, then the last trade price of
such security prior to 4:00:00 p.m., New York time, as reported by Bloomberg,
or, if the Principal Market is not the principal securities exchange or trading
market for such security in the United States, the last trade price of such
security on the principal securities exchange or trading market in the United
States where such security is listed or traded as reported by Bloomberg, or if
the foregoing does not apply, the last trade price of such security in the
over-the-counter market on the electronic bulletin board for such security as
reported by Bloomberg, or, if no last trade price is reported for such security
by Bloomberg, the average of the ask prices of any market makers for such
security as reported on Pink Quote published by Pink OTC Markets Inc. (formerly
Pink Sheets). If the Closing Sale Price cannot be calculated for a security on a
particular date on any of the foregoing bases, the Closing Sale Price of such
security on such date shall be the fair market value as mutually determined by
the Company and the Holder. If the Company and the Holder are unable to agree
upon the fair market value of such security, then such dispute shall be resolved
in accordance with the procedures in Section 13. All such determinations
shall be appropriately adjusted for any stock dividend, stock split, stock
combination or other similar transaction during such period.

8

(c) “Common Shares” means
(i) shares of the Company’s common stock, $0.001 par value (the “Common
Stock”), and (ii) any share capital into which such Common Stock shall have
been changed or any share capital resulting from a reclassification of such
Common Stock.

(d) “Eligible Market”
means The New York Stock Exchange, Inc., The NYSE MKT Equities or The NASDAQ
Stock Market. 

(e) “Expiration Date”
means the date sixty (60) months following the Issuance Date or, if such
date falls on a day on which trading does not take place on the Principal Market
(a “Holiday”), the next date that is not a Holiday. 

(f) “Fundamental
Transaction” means that (A) the Company shall, directly or indirectly, in
one or more related transactions, (i) consolidate or merge with or into (whether
or not the Company is the surviving corporation) another Person, or (ii) sell,
assign, transfer, convey or otherwise dispose of all or substantially all of the
properties or assets of the Company to another Person, or (iii) allow another
Person to make a purchase, tender or exchange offer that is accepted by the
holders of more than the 50% of the outstanding Common Shares (not including any
Common Shares held by the Person or Persons making or party to, or associated or
affiliated with the Persons making or party to, such purchase, tender or
exchange offer), or (iv) consummate a stock purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization,
spin-off or scheme of arrangement) with another Person whereby such other Person
acquires more than 50% of the outstanding Common Shares (not including any
Common Shares held by the other Person or other Persons making or party to, or
associated or affiliated with the other Persons making or party to, such stock
purchase agreement or other business combination), or (v) reorganize,
recapitalize or reclassify the Common Stock, or (B) any “person” or “group” (as
these terms are used for purposes of Sections 13(d) and 14(d) of the Exchange
Act) is or shall become the “beneficial owner” (within the meaning of Rule 13d-3
under the Exchange Act), directly or indirectly, of 50% of the aggregate
ordinary voting power represented by issued and outstanding Common Stock.

(g) “Parent Entity” of a
Person means an entity that, directly or indirectly, controls the applicable
Person and whose common stock or equivalent equity security is quoted or listed
on an Eligible Market, or, if there is more than one such Person or Parent
Entity, the Person or Parent Entity with the largest public market
capitalization as of the date of consummation of the Fundamental Transaction.

9

(h) “Person” means an
individual, a limited liability company, a partnership, a joint venture, a
corporation, a trust, an unincorporated organization, any other entity and a
government or any department or agency thereof. 

(i) “Principal Market”
means The NASDAQ Capital Market. 

(j) “Successor Entity”
means the Person (or, if such Person’s common stock or equivalent equity
security is not quoted or listed on an Eligible Market, the Parent Entity)
formed by, resulting from or surviving any Fundamental Transaction or the Person
(or, if so elected by the Holder, the Parent Entity) with which such Fundamental
Transaction shall have been entered into.

(k) “Trading Day” means
any day on which the Common Shares are traded on the Principal Market, or, if
the Principal Market is not the principal trading market in the United States
for the Common Shares, then on the principal securities exchange or securities
market in the United States on which the Common Shares are then traded; provided
that “Trading Day” shall not include any day on which the Common Shares are
scheduled to trade on such exchange or market for less than 4.5 hours or any day
that the Common Shares are suspended from trading during the final hour of
trading on such exchange or market (or if such exchange or market does not
designate in advance the closing time of trading on such exchange or market,
then during the hour ending at 4:00:00 p.m., New York time).

(l) “VWAP” means, for any
date, the price determined by the first of the following clauses that applies:
(a) if the Common Shares are then listed or quoted on the Principal Market or an
Eligible Market, the daily volume weighted average price of the Common Shares
for such date (or the nearest preceding date) on the trading market on which the
Common Shares are then listed or quoted as reported by Bloomberg L.P. (based on
a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City
time), (b) if then quoted on the OTC Bulletin Board, the volume weighted average
price of the Common Shares for such date (or the nearest preceding date) on the
OTC Bulletin Board, (c) if the Common Shares are not then listed or quoted for
trading on the OTC Bulletin Board and if prices for the Common Shares are then
reported on Pink Quote published by Pink OTC Markets Inc. (or a similar
organization or agency succeeding to its functions of reporting prices), the
most recent bid price per Common Share so reported, or (d) in all other cases,
the fair market value of one Common Share as determined by an independent
appraiser reasonably acceptable to the Company and selected in good faith by the
Holder, the fees and expenses of which shall be paid by the Company.

[Signature Page Follows] 

10

IN WITNESS WHEREOF, the
Company has caused this Warrant to Purchase Common Shares to be duly executed as
of the Issuance Date set out above. 

	 	LIGHTBRIDGE CORPORATION 
	 	  
	 	By:___________________________ 
	 	       Name: 
	 	       Title:

[Signature Page to Warrant]

EXHIBIT A 

EXERCISE NOTICE 

TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS

WARRANT TO PURCHASE COMMON SHARES 

LIGHTBRIDGE CORPORATION 

The undersigned holder hereby
exercises the right to purchase _________of the Common Shares (“Warrant
Shares”) of Lightbridge Corporation, a Nevada corporation (the
“Company”), evidenced by the attached Warrant to Purchase Common Shares
(the “Warrant”). Capitalized terms used herein and not otherwise defined
shall have the respective meanings set forth in the Warrant. 

1. Payment of Exercise
Price. 

	 	[  ] 	The holder shall pay the Aggregate Exercise
      Price in the sum of $_____to the Company in accordance with the terms of
      the Warrant. 
	 	  	  
	 	[  ] 	The holder elects or must utilize Cashless
      Exercise. 

2. Delivery of Warrant
Shares. The Company shall deliver to the holder _________Warrant Shares in
accordance with the terms of the Warrant and, after delivery of such Warrant
Shares, _________Warrant Shares remain subject to the Warrant. 

3. Representations and
Warranties. By its delivery of this Exercise Notice, the undersigned
represents and warrants to the Company that in giving effect to the exercise
evidenced hereby the holder will not beneficially own in excess of the number of
Common Shares (determined in accordance with Section 13(d) of the Securities
Exchange Act of 1934) permitted to be beneficially owned under Section 1(d)
of the Warrant.

Date: ________, ______

Name of Registered holder

By: _________________
Name: 
Title:

ACKNOWLEDGMENT 

The Company hereby acknowledges
this Exercise Notice and hereby directs Computershare Trust Company to issue the
above indicated number of Common Shares in accordance with the Transfer Agent
Instructions dated [_________] from the Company [and acknowledged and agreed to
by Computershare Trust Company].

	 	LIGHTBRIDGE CORPORATION 
	 	  
	 	By:__________________________ 
	 	     Name: 
	 	     Title:

EXHIBIT B 

ASSIGNMENT FORM 

LIGHTBRIDGE CORPORATION 

(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form
to purchase shares.) 

FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to 

	Name: 
	 	  
	 	(Please Print) 
	 	 
	Address: 
	 	(Please Print) 

Dated: ______________, _____

Holder’s Signature: 

Holder’s Address: __________________

NOTE: The signature to this Assignment Form must correspond
with the name as it appears on the face of the Warrant, without alteration or
enlargement or any change whatever. Officers of corporations and those acting in
a fiduciary or other representative capacity should file proper evidence of
authority to assign the foregoing Warrant.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00261-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00261-of-00352.parquet"}]]